Ina Research Of Japan To Offer Lab Testing Of iPS Cell Transplants
This article was originally published in PharmAsia News
Executive Summary
Japan's Ina Research said it is expanding beyond its contract research business to offer studies of the safety of induced pluripotent stem cell transplants, using its own laboratory technology.